PTGS2 and neoplasm: The COX-2 upregulation in synchronous metastases supports its association with tumour invasiveness and metastatic process because COX-2 affects cell proliferation, tumour growth, angiogenesis, apoptosis resistance and immune response (Sheng et al, 1997; Chen et al, 2001).